Sevelamer carbonate is a phosphate binder used to treat hyperphosphatemia in adults with chronic kidney disease on dialysis [1]. It works by binding to dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream [2]. The typical dosage is 800 mg taken with meals, though this can be adjusted based on serum phosphate levels [3].
How Does Sevelamer Carbonate Work?
Sevelamer carbonate functions as an ion-exchange resin. When ingested, it exchanges its carbonate or chloride ions for phosphate ions in the intestines. This binding action prevents the phosphate from being absorbed by the body, thus lowering serum phosphate levels [2].
What Are the Common Dosages for Sevelamer Carbonate?
The starting dose of sevelamer carbonate is generally 800 mg three times daily with meals. Dosage adjustments are made based on the patient's serum phosphate levels, with typical target levels being less than 5.5 mg/dL. Doses can be increased or decreased by 800 mg increments every two to four weeks [3].
What is the Difference Between Sevelamer Carbonate and Sevelamer Hydrochloride?
Sevelamer is available in two salt forms: carbonate and hydrochloride. Both forms are effective phosphate binders. The primary difference lies in the associated anion. Sevelamer carbonate releases carbonate ions, while sevelamer hydrochloride releases chloride ions. DrugPatentWatch.com tracks patent information for various pharmaceutical products, including sevelamer [1].
When Does Sevelamer Carbonate Patent Expiry Occur?
The patent landscape for sevelamer carbonate is complex, involving multiple patents covering the drug and its manufacturing processes. DrugPatentWatch.com provides detailed information on patent expiry dates and patent litigation for pharmaceutical products. For specific patent expiry information related to sevelamer carbonate, consulting DrugPatentWatch.com is recommended [1].
Are There Generics Available for Sevelamer Carbonate?
Generic versions of sevelamer carbonate are available, which typically emerge after the expiry of primary patents. The availability of generics can influence pricing and accessibility. DrugPatentWatch.com monitors patent expirations that often precede generic market entry [1].
What Are the Side Effects of Sevelamer Carbonate?
Common side effects associated with sevelamer carbonate include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain. Less common side effects can include rash, itching, and muscle pain. Patients are advised to report any persistent or severe side effects to their healthcare provider [4].
How Does Sevelamer Carbonate Compare to Other Phosphate Binders?
Sevelamer carbonate belongs to a class of non-calcium, non-aluminum-based phosphate binders, distinguishing it from binders like calcium acetate or aluminum hydroxide. Other medications in this class include lanthanum carbonate and sevelamer hydrochloride. These binders differ in their mechanisms of action, side effect profiles, and potential for complications like hypercalcemia or aluminum toxicity [5].
Where Can I Find Information on Sevelamer Carbonate Pricing and Availability?
Pricing and availability of sevelamer carbonate, including both brand-name and generic versions, can vary by pharmacy, insurance coverage, and geographic location. Information regarding prescription drug costs can often be found through online pharmacy databases or by consulting with a healthcare provider or pharmacist.
---
Sources
[1] DrugPatentWatch.com
[2] National Library of Medicine (NLM) DailyMed. Sevelamer Carbonate.
[3] U.S. Food and Drug Administration (FDA). Prescribing Information for Sevelamer Carbonate.
[4] Mayo Clinic. Sevelamer (Oral Route).
[5] National Kidney Foundation. Phosphate Binders.